1. Home
  2. REAL vs ENGN Comparison

REAL vs ENGN Comparison

Compare REAL & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The RealReal Inc.

REAL

The RealReal Inc.

HOLD

Current Price

$15.56

Market Cap

1.7B

ML Signal

HOLD

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

HOLD

Current Price

$9.22

Market Cap

379.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
REAL
ENGN
Founded
2011
1999
Country
United States
Canada
Employees
N/A
N/A
Industry
Other Specialty Stores
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
379.3M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
REAL
ENGN
Price
$15.56
$9.22
Analyst Decision
Buy
Buy
Analyst Count
8
7
Target Price
$15.29
$22.71
AVG Volume (30 Days)
2.7M
283.0K
Earning Date
11-10-2025
12-22-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$662,789,000.00
N/A
Revenue This Year
$17.10
N/A
Revenue Next Year
$10.96
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.30
N/A
52 Week Low
$4.61
$2.65
52 Week High
$16.24
$11.14

Technical Indicators

Market Signals
Indicator
REAL
ENGN
Relative Strength Index (RSI) 63.39 62.85
Support Level $14.02 $7.57
Resistance Level $16.08 $8.47
Average True Range (ATR) 0.75 0.69
MACD 0.06 0.07
Stochastic Oscillator 72.83 78.18

Price Performance

Historical Comparison
REAL
ENGN

About REAL The RealReal Inc.

The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: